95% OR | ||
---|---|---|
In-championship illness | ||
Simple models | Multiple model | |
Sex | NS | |
Age | 1.17 (1.02 to 1.33) (p=0.022) | |
Continent (reference Europe) | NS | |
Africa | NS | |
Asia | NS | |
Australia | NS | |
North America | NS | |
South America | NS | |
Event category (reference speed/power) Endurance (middle and long distance running, marathon, race walking) | 9.88 (1.20 to 81.31) (p=0.033) | 9.88 (1.20 to 81.31) (p=0.033) |
Prechampionships medical support available | NS | |
Preparticipation health symptoms | ||
Injury symptoms | ||
Reduced participation | NS | |
Gradual-onset | NS | |
Severity score | NS | |
Notable duration (>2 days) | NS | |
Anxiety caused | NS | |
Expected impact at championships | NS | |
Illness symptoms | ||
Reduced participation | NS | |
Severity score | NA | |
Notable duration (>2 days) | NS | |
Anxiety caused | NS |
NA, not applicable; NS, not significant.